Established and novel, potential risk factors for thrombosis in patients with polycythemia vera (PV) or essential thrombocythemia (ET).
. | Established risk factors . | Potential risk factors . |
---|---|---|
PV | Age ≥ 60 y | Leukocytosis41 |
Previous thrombosis | V617F allele ≥ 75%48 | |
ET | Age ≥ 60 y | Leukocytosis42 |
Previous thrombosis | JAK2V617F mutation44 | |
Platelets ≥ 1500 x 109/L | JAK2V617F homozygosity33 |
. | Established risk factors . | Potential risk factors . |
---|---|---|
PV | Age ≥ 60 y | Leukocytosis41 |
Previous thrombosis | V617F allele ≥ 75%48 | |
ET | Age ≥ 60 y | Leukocytosis42 |
Previous thrombosis | JAK2V617F mutation44 | |
Platelets ≥ 1500 x 109/L | JAK2V617F homozygosity33 |